Best Outsourced CFO Firms for Seed-Stage Biotech Startups (2026)

• What a Seed-Stage Biotech Needs From a Finance Lead
• Comparison of Outsourced CFO Firms for Seed-Stage Biotech
• Firm Profiles
  • K-38 Consulting
  • Burkland Associates
  • Pilot
  • Kruze Consulting
  • Astute
• How to Choose
• Fractional CFO vs Controller vs Bookkeeper Before Series A
• FAQ
  • How much does an outsourced CFO cost for a seed-stage biotech?
  • Do I need a CFO or a controller before Series A?
  • Can an outsourced CFO help me claim R&D tax credits?
  • Is Pilot a good choice for a biotech startup?
  • What should a biotech CFO deliver in the first few months?
• Conclusion

For seed-stage biotech, the best outsourced CFO firms tie cash runway to clinical and R&D milestones, produce board-ready reporting, and prepare you for the next raise. K-38 Consulting fits biotech founders who want a CFO-plus-controller team on a firm engagement. Burkland Associates fits VC-backed startups that want a pure startup specialist, and Pilot fits teams that mainly need bookkeeping.

Pricing below is labeled public or third-party reported. Treat it as a signal, not a quote. It may have changed.

What a Seed-Stage Biotech Needs From a Finance Lead

A seed-stage biotech does not have a revenue problem. It has a runway problem. Every dollar sits against a milestone, and a missed milestone can sink your next raise.

That changes what you should ask a finance lead to do. Five jobs matter most:

• Cash runway tied to milestones. Your forecast should move when a trial timeline slips or a CRO invoice lands early, not only when payroll changes.
• Board-ready reporting. Investors want burn, runway, and variance to plan in a format they can read in minutes.
• Fundraising preparation. A clean model and an organized data room shorten diligence.
• R&D tax credits. Qualifying research spend can generate credits worth up to $250,000 or more for qualifying businesses. Eligibility depends on your facts, and nothing is guaranteed.
• Grant tracking. Non-dilutive funding comes with reporting rules, and mixing grant dollars with equity dollars creates cleanup work later.

A bookkeeper records what happened. A biotech CFO explains what it means for the next 18 months. Most seed-stage founders need the second function, even if the budget only covers part of it.

Comparison of Outsourced CFO Firms for Seed-Stage Biotech

Firm Profiles

K-38 Consulting

K-38 Consulting is a Raleigh, NC-based, remote-first firm that embeds CFO and controller talent into growing companies. Biotech is one of the industries it serves. Services include fractional CFO, outsourced CFO, controller services, Startup CFO Services (financial modeling, fundraising support, and growth strategy), R&D tax credit services, cost segregation, and accounting automation.

The delivery model is the differentiator. You work with a firm, with a CFO and controller team providing continuity, rather than a single freelancer match. If one person is out, your books and forecast keep moving.

Retainers run roughly $1,750-$3,000/month at entry, $5,000-$7,000/month mid-tier, and $10,000-$12,000+/month premium. Hourly work runs $175-$375, and a cash-plus-equity structure starts from about $3,500/month plus equity. Final pricing is engagement-specific and quote-based. The fractional CFO pricing guide explains what drives the range.

Burkland Associates

Burkland is a startup and VC specialist, and its website states it has served more than 800 startups. Its services include financial modeling, cash and treasury management, fundraising support, and board-ready reporting.

If you are VC-backed and want a firm that works almost exclusively with venture-funded companies, Burkland is a strong fit. For a side-by-side look at how the two firms differ for life sciences, see the K-38 vs Burkland biotech comparison.

Pilot

Pilot is AI and software-led. Its Essentials tier costs $99/month. Its Core tier runs about $499-$599/month, and its CFO tier starts around $1,750/month and reaches $5,250+. The Core and CFO figures are third-party reported (via a Zeni review), so confirm them with Pilot directly.

Pilot’s approach is productized and less bespoke. That works when your main need is clean books at a predictable price. It is a weaker match when your forecast depends on trial timelines, CRO payment schedules, and grant reporting that call for custom judgment.

Kruze Consulting

Kruze serves VC-backed startups, and its accounting tiers run $650-$1,500/month. It is accounting-first, which suits founders who need solid books and tax compliance for a venture-funded company before they layer on heavier CFO work.

Astute

Astute (thinkastute.com) offers fractional CFO advisory and publishes biotech-focused content. That content covers clinical trial timelines, CRO payments, and how grants and licensing show up in forecasts. If you want an advisor who speaks that language, put Astute on your shortlist and ask for a scoped proposal.

CFO Advisors is also worth a look if you are building a longer list. Verify its biotech experience directly.

How to Choose

Four questions separate the firms quickly.

Scope. Do you need books closed, a forecast built, a fundraise supported, or all three? A bookkeeping-first firm and a CFO-led firm solve different problems.

Biotech depth. Ask how they model a clinical milestone that slips by two quarters. Ask how they treat CRO commitments and grant reimbursements. Vague answers tell you what you need to know.

Pricing clarity. Public pricing helps, but a clear scope helps more. Be wary of any quote you cannot map to specific deliverables. Final pricing at most firms, K-38 included, depends on your engagement.

Continuity. Who covers when your finance lead is unavailable? A firm engagement with a CFO plus controller team protects you from single-person risk. A freelancer can be excellent, but your finance function then depends on one calendar.

Fractional CFO vs Controller vs Bookkeeper Before Series A

Before Series A, most biotech startups do not need all three at full strength. They need the right one at the right time.

• Bookkeeper: records transactions and reconciles accounts. This is enough when you have a few vendors, no grants, and a short runway you can track by hand.
• Controller: owns the close, financial statements, and internal controls. You need one once you have multiple funding sources, CRO contracts, or investor reporting. See the part-time controller service.
• Fractional CFO: owns the forecast, runway, fundraising model, and board narrative. You need one when investors start asking hard questions about milestones and burn.

A full-time CFO costs roughly $350k+ on an approximate fully-loaded basis, which is rarely realistic at seed stage. Many founders start with a controller or a fractional CFO and add the other as complexity grows.

FAQ

How much does an outsourced CFO cost for a seed-stage biotech?

It depends on scope. K-38’s fractional CFO retainers run $1,750-$3,000/month at entry, $5,000-$7,000/month mid-tier, and $10,000-$12,000+/month premium, with hourly work at $175-$375. Third-party reported figures put Pilot’s CFO tier at about $1,750/month and up. All pricing may have changed, and K-38’s final pricing is quote-based.

Do I need a CFO or a controller before Series A?

Often the controller comes first, because clean, closed books are the foundation for everything else. Add a fractional CFO when you need milestone-based forecasting, fundraising support, and board reporting. Some founders run both through one firm.

Can an outsourced CFO help me claim R&D tax credits?

Yes. K-38 offers R&D tax credit services, and credits can be worth up to $250,000 or more for qualifying businesses. Qualification depends on your research activities and documentation, and no outcome is guaranteed.

Is Pilot a good choice for a biotech startup?

If you mainly need bookkeeping at a predictable price, yes. If your forecast depends on trial timelines, CRO payments, and grants, a more bespoke CFO engagement usually fits better.

What should a biotech CFO deliver in the first few months?

Expect a reconciled set of books, a runway forecast tied to your milestones, and a reporting package your board can read quickly. Timing depends on the state of your records, so no firm should promise a fixed turnaround.

Conclusion

The best outsourced CFO for a seed-stage biotech ties your cash to your milestones and keeps working when one person is out. Choose Burkland if you want a pure VC-startup specialist, Pilot if bookkeeping comes first, and K-38 Consulting if you want a CFO and controller team built around biotech funding realities.

Ready to scope it? Get a Free Quote.